Mechlorethamine
Links shared publicly online about this topic
NDA Accepted for Mechlorethamine Gel for Mycosis Fungoides - MPR
empr.com — “Yaupon Therapeutics announced the FDA accepted its new drug application (NDA) for its propriety gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, the most common type of cutaneous T-Cell lymphoma (CTCL).” View full resource at empr.com
Most Recently Shared on October 4, 2011 at 2:39 pm By:
NDA Accepted for Mechlorethamine Gel for Mycosis Fungoides http://ow.ly/6MZHV #oncology
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement
